Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nova Leap HealthNVLPF 50 Earnings Yield (Joel Greenblatt) % is 3.21% as of Mar. 2026. GuruFocus rates NVLPF with a GF Score™ of 50/100 and a GF Value™ of $0.23 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 686 Healthcare Providers & Services companies, Nova Leap Health ranks worse than 52.48% on this metric.
Nova Leap Health's Enterprise Value for the quarter that ended in Mar. 2026 was $23.64 Mil.
Nova Leap Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $0.75 Mil. Nova Leap Health's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was 3.21%.
The historical rank and industry rank for Nova Leap Health's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
NVLPF'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -44.09 Med: -1.98 Max: 12.02
Current: 2.96
During the past 10 years, the highest Earnings Yield (Joel Greenblatt) of Nova Leap Health was 12.02%. The lowest was -44.09%. And the median was -1.98%.
NVLPF's Earnings Yield (Joel Greenblatt) % is ranked worse than 52.48% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 3.24
vs NVLPF: 2.96
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Nova Leap Health's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Nova Leap Health (OTCPK:NVLPF) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Nova Leap Health Earnings Yield (Joel Greenblatt) % Related Terms
Nova Leap Health Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Nova Leap Health's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nova Leap Health Earnings Yield (Joel Greenblatt) % Chart
For the Medical Care Facilities subindustry, Nova Leap Health's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Leap Health Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Nova Leap Health's Earnings Yield (Joel Greenblatt) % falls into.
Nova Leap Health Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Nova Leap Healths Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
Nova Leap Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.75 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 3.21% mean?
Nova Leap Health (NVLPF) has a Earnings Yield (Joel Greenblatt) % of 3.21% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Nova Leap Health and its competitors. According to the industry distribution chart, Nova Leap Health ranks #360 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 52.5%.
Is Nova Leap Health's Earnings Yield (Joel Greenblatt) % too high?
Nova Leap Health's current Earnings Yield (Joel Greenblatt) % is 3.21%. The Healthcare Providers & Services industry median Earnings Yield (Joel Greenblatt) % is 3.24. Nova Leap Health's value of 3.21% is 0.9% below this industry median. Based on the distribution chart, Nova Leap Health ranks #360 out of 686 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Nova Leap Health has a GF Score™ of 50/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's Earnings Yield (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nova Leap Health ranks #360 out of 686 companies for Earnings Yield (Joel Greenblatt) %. This places Nova Leap Health in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.24. Nova Leap Health's value of 3.21% is 0.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.24, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nova Leap Health's current Earnings Yield (Joel Greenblatt) % of 3.21% is 0.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Nova Leap Health and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova Leap Health's current Earnings Yield (Joel Greenblatt) % is 3.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.23, compared to a current price of $0.26 — trading 13% above its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 3.21% and 0.9% below the Healthcare Providers & Services industry median of 3.24. Nova Leap Health's overall GF Score™ is 50/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current Earnings Yield (Joel Greenblatt) % is 3.21% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nova Leap Health (NVLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued.
The current stock price of $0.26 is trading 13% above its estimated GF Value™ of $0.23.
GuruFocus considers Nova Leap Health to be Modestly Overvalued.
Key valuation signals for NVLPF:
Earnings Yield (Joel Greenblatt) %: 3.21%
GF Value™: $0.23 vs. price of $0.26 (13% above fair value)
Industry Position: 0.9% below the Healthcare Providers & Services median (#360 of 686)
No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
50GF Score
Get the complete analysis for NVLPF
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NVLPF has been successfully added to your 
